Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Metabolism: Clinical and Experimental|November 17, 2024
Metabolic dysfunction-associated steatotic liver disease and urinary system cancers: Mere coincidence or reason for concern?Fernando Bril, Alicia ElbertMedicina|January 11, 2005
[Effect of the temperature of the dialysis bath in diabetics]Cintia N Galli, Mirta López, Hugo Beresan, et al.Current Diabetes Reports|January 6, 2025
Impact of SGLT2 Inhibitors on Lipoproteins in Type 2 DiabetesPablo Corral, Natalia Nardelli, Alicia Elbert, et al.Metabolism: Clinical and Experimental|July 29, 2004
Utility of non-high-density lipoprotein cholesterol in hemodialyzed patientsLaura Schreier, Ana I González, Alicia Elbert, et al.Medicina|July 29, 2022
[Renal effects of GLP-1 agonists in type 2 diabetes]Alicia Elbert, Carlos Castellaro, Leon Litwak, et al.Medicina|October 19, 2017
[Insulin therapy in special conditions]León E Litwak, Alicia Elbert, Cristina Faingold, et al.Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|October 19, 2006
Prevalence of impaired fasting glycemia, impaired glucose tolerance, and type 2 diabetes in hemodialyzed patients when applying new diagnostic criteriaAlicia Elbert, Laura Schreier, Cinthia Galli, et al.Archivos De Cardiologia De Mexico|July 14, 2021
[Relación entre enfermedad cardiovascular y renal en una muestra de pacientes con diabetes del mundo real]Emiliano Salmeri, Alicia Elbert, Augusto Lavalle-Cobo, et al.Scandinavian Journal of Clinical and Laboratory Investigation|November 26, 2008
Assessment of salivary urea as a less invasive alternative to serum determinationsEstela M L Cardoso, Alejandro L Arregger, Omar R Tumilasci, et al.Metabolism: Clinical and Experimental|January 14, 2003
Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patientsAna Inés González, Laura Schreier, Alicia Elbert, et al.Pageof 2